Biosimilars Market
Biosimilars Market - Global Industry Assessment & Forecast
#
Pages:
155
Base Year:
2022
Oct - 2024
Format:
Report Code:
VMR-1279
Segments Covered
By
Product Class Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, Other Product Classes
-
By
Application Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other Applications
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 35.14 Billion |
 Revenue 2030:
|
USD 216.32 Billion |
 Revenue CAGR
(2023 - 2030): |
25.50% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
Europe |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Biosimilars Market Segment Analysis
- Biosimilars Product Class Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Biosimilars Application Outlook (Revenue, USD Million, 2018 - 2030)
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
-
North America Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- U.S.
- U.S. Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- U.S. Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- U.S. Biosimilars Market, by Product Class
- Canada
- Canada Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Canada Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Canada Biosimilars Market, by Product Class
-
Mexico
- Mexico Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Mexico Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Mexico Biosimilars Market, by Product Class
-
North America Biosimilars Market, by Product Class
- Europe
-
Europe Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
-
Europe Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- U. K.
- U.K. Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- U.K. Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- U.K. Biosimilars Market, by Product Class
- France
- France Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- France Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- France Biosimilars Market, by Product Class
-
Germany
- Germany Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Germany Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Germany Biosimilars Market, by Product Class
-
Italy
- Italy Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Italy Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Italy Biosimilars Market, by Product Class
-
Spain
- Spain Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Spain Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Spain Biosimilars Market, by Product Class
-
Rest of Europe
- Rest of Europe Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Rest of Europe Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Rest of Europe Biosimilars Market, by Product Class
-
Europe Biosimilars Market, by Product Class
- Asia Pacific
-
Asia Pacific Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
-
Asia Pacific Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- China
- China Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- China Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- China Biosimilars Market, by Product Class
- Japan
- Japan Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Japan Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Japan Biosimilars Market, by Product Class
-
Germany
- Germany Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Germany Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Germany Biosimilars Market, by Product Class
-
India
- India Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- India Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- India Biosimilars Market, by Product Class
-
South Korea
- South Korea Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- South Korea Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- South Korea Biosimilars Market, by Product Class
-
South East Asia
- South East Asia Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- South East Asia Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- South East Asia Biosimilars Market, by Product Class
-
Rest of Asia Pacific
- Rest of Asia Pacific Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Rest of Asia Pacific Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Rest of Asia Pacific Biosimilars Market, by Product Class
-
Asia Pacific Biosimilars Market, by Product Class
- Latin America
-
Latin America Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
-
Latin America Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Brazil
- Brazil Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Brazil Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Brazil Biosimilars Market, by Product Class
- Argentina
- Argentina Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Argentina Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Argentina Biosimilars Market, by Product Class
-
Rest of Latin America
- Rest of Latin America Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Rest of Latin America Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Rest of Latin America Biosimilars Market, by Product Class
-
Latin America Biosimilars Market, by Product Class
- Middle East & Africa
-
Middle East & Africa Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
-
Middle East & Africa Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- GCC Countries
- GCC Countries Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- GCC Countries Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- GCC Countries Biosimilars Market, by Product Class
- South Africa
- South Africa Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- South Africa Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- South Africa Biosimilars Market, by Product Class
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Biosimilars Market, by Product Class
- Monoclonal Antibodies
- Recombinant Hormones
- Immunomodulators
- Anti-Inflammatory Agents
- Other Product Classes
- Rest of Middle East & Africa Biosimilars Market, by Application
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Oncology
- Other Applications
- Rest of Middle East & Africa Biosimilars Market, by Product Class
-
Middle East & Africa Biosimilars Market, by Product Class
- North America
Vantage Market
Research | 09-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Biosimilars in terms of revenue?
-
The global Biosimilars valued at USD 35.14 Billion in 2022 and is expected to reach USD 216.32 Billion in 2030 growing at a CAGR of 25.50%.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche Ltd. (US), Sandoz International GmbH (Switzerland), Dr. Reddy’s Laboratories Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (US), Samsung Bioepis (South Korea), Biocon (India), and Mylan N.V (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 25.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Biosimilars include
- Increasing Demand for Biosimilar Drugs due to their Cost-Effectiveness
Which region accounted for the largest share in the market?
-
Europe was the leading regional segment of the Biosimilars in 2022.
